Praxis Precision Medicines Announces November Conference Participation
BOSTON — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a dedicated clinical-stage biopharmaceutical company focused on advancing therapies for central nervous system (CNS) disorders, has shared its plans to engage in several prominent investor conferences this November. These conferences present a prime opportunity for the company's management to connect with investors, discuss its innovations, and shed light on its current projects aimed at addressing critical CNS issues.
Details of Conference Participation
Truist Securities BioPharma Symposium
One of the standout events will be at the Truist Securities BioPharma Symposium, where Praxis leadership will take part in a fireside chat scheduled for November 7. This chat will be held at the Lotte New York Palace Hotel in New York City, beginning at 9:40 AM ET. This event is anticipated to be a key touchpoint for exchanging ideas and insights into the biopharmaceutical landscape.
Guggenheim Securities Healthcare Innovation Conference
Subsequently, on November 11, Praxis management will also join the Guggenheim Securities Inaugural Healthcare Innovation Conference at the InterContinental in Boston. Starting at 1:00 PM ET, this fireside chat will delve into the innovative strides being made in the field. Investors interested in hearing the discussions can access a live webcast of this event through the company's investor relations platform.
Jefferies London Healthcare Conference
The third event on the agenda is the Jefferies London Healthcare Conference, taking place on November 20-21. Here, Praxis will engage in one-on-one meetings with potential investors, further fostering relationships to support its ongoing projects.
Investor Engagement and Q&A Opportunities
The Company encourages interested investors to reach out to their corporate access representatives to set up one-on-one meetings during the Truist and Guggenheim conferences. This initiative highlights Praxis's commitment to maintaining transparency and accessibility as it advances its portfolio.
Live Webcast Access and Availability
For those unable to attend in person, a live webcast of the fireside chat at the Guggenheim conference will be available through the “Upcoming & Recent Events” section on the company’s website. Additionally, following the event, a replay will be accessible on the Events and Presentations page for 90 days, allowing others to catch up on the insights shared.
About Praxis Precision Medicines
Praxis Precision Medicines operates as a vanguard in the field of biopharmaceuticals, leveraging genetic insights gained from the study of epilepsy to develop cutting-edge therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. The company is dedicated to innovative breakthroughs through its proprietary platforms such as Cerebrum™ and Solidus™. These platforms enable the discovery and development of therapies aimed at both rare and widespread neurological conditions. Currently, Praxis boasts a diverse CNS portfolio, featuring multiple clinical-stage product candidates aimed at movement disorders and epilepsy.
Frequently Asked Questions
What is the purpose of Praxis Precision Medicines participating in these conferences?
The participation allows Praxis to connect with investors, discuss advancements in their projects, and showcase their innovative strategies for addressing CNS disorders.
When and where will the Truist Securities BioPharma Symposium be held?
The Truist Securities BioPharma Symposium is scheduled for November 7 at the Lotte New York Palace Hotel in New York City, beginning at 9:40 AM ET.
Will there be online access to the Guggenheim Healthcare Innovation Conference?
Yes, a live webcast of the Guggenheim fireside chat will be available on the company’s investor relations platform.
Which platforms does Praxis use for therapy development?
Praxis utilizes two proprietary platforms, Cerebrum™ for small molecule therapies and Solidus™ for antisense oligonucleotides (ASOs), to develop treatments for CNS disorders.
How can investors schedule one-on-one meetings with company management?
Investors interested in meetings should contact their corporate access representatives at the respective conferences to request appointments.
